Issue 4, September 2006
Health Care Choice Gets a Lift
Health care choice continues to press ahead. The latest step forward was the recent election of health care pioneer Dr. Brian Day as President-Elect of the Canadian Medical Association. Overall, the events of last three summers have heralded tectonic changes in the Canadian health care landscape. These positive developments make for a remarkable story. Read more...
Health Care Betrayal – Where Canada’s Health Care Fails
Health Care in Canada is in crisis! How many times have you
heard that statement? After recent experiences with my own family’s adventure along the road of accessing health care in Alberta, I can say
Canadians have been betrayed and will not realize it, unless one tries to access a specialist, tests, etc that are not emergencies.
A Ministerial Task Force has been established under the direction of the First Ministers to develop and implement a National Pharmaceutical Strategy. The Task Force is to report on its progress in less than six months. The Task Force, which has now been working to its ultimate goal of a National Pharmaceutical Strategy for well over a year, is missing a key and decisive element, collaborating with stakeholders on innovative solutions. Read more...
Health Care Laws Challenged in Alberta Courts
A chartered accountant named Bill Murray has
launched a constitutional challenge to Alberta's health-care laws, which are almost identical to the Quebec law struck down by the Supreme Court of
Canada last year in the landmark case of Chaoulli v. Quebec.
International PET Diagnostics Inc. (“IPET”) has added another first to its leadership position in the provision of diagnostic imaging services to cancer patients and their doctors. IPET was the first in Canada to make PET scans available to cancer patients on a doctor referral basis when it opened the Vancouver PETSCAN Centre six years ago. One month ago IPET Pharmaceuticals Inc. became the first in Canada to be issued a Health Canada Notice of Compliance (NOC) for the radiopharmaceutical drug, FDG, used in PET scanning. Read more...